Picture of IntegraGen SA logo

ALINT — IntegraGen SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: OncoDNA To File Friendly Takeover Bid On IntegraGen At EUR 2.20/Share

July 9 (Reuters) - Integragen SA  ALINT.PA :
    * AGREEMENT TO FILE A FRIENDLY TAKEOVER BID INITIATED BY ONCODNA ON INTEGRAGEN TO ACQUIRE
ALL
OUTSTANDING SHARES AT A PRICE OF 2.20€ PER SHARE
    * PRICE PER SHARE OF EUR 2.20, VALUING INTEGRAGEN SHARE CAPITAL AT EUR 14.5M FOR 100%
    * THIS TRANSACTION REPRESENTS A PREMIUM OF +36.2% COMPARED TO LAST CLOSING PRICE OF
INTEGRAGEN
SHARES
    * OFFER WAS APPROVED ON A UNANIMOUS BASIS BY ALL MEMBERS OF BOARD OF BOTH COMPANIES.
    * ONCODNA IS ADVISED BY ODDO BHF, WHITE & CASE AND OSBORNE CLARKE
    * INTEGRAGEN IS ADVISED BY PORTZAMPARC AND JONES DAYS.
    * PUBLIC OFFER SHALL BE OPENED AT END OF Q3 OF 2020
    * ONCODNA CURRENTLY OWNS NO SHARE OF INTEGRAGEN

Source text for Eikon:  ID:nBw7xr487a 
Further company coverage:  ALINT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on IntegraGen SA

See all news